171 related articles for article (PubMed ID: 14597144)
1. Aberrant sphingomyelin/ceramide metabolic-induced neuronal endosomal/lysosomal dysfunction: potential pathological consequences in age-related neurodegeneration.
Soreghan B; Thomas SN; Yang AJ
Adv Drug Deliv Rev; 2003 Nov; 55(11):1515-24. PubMed ID: 14597144
[TBL] [Abstract][Full Text] [Related]
2. Neuronal endosomal/lysosomal membrane destabilization activates caspases and induces abnormal accumulation of the lipid secondary messenger ceramide.
Ditaranto-Desimone K; Saito M; Tekirian TL; Saito M; Berg M; Dubowchik G; Soreghan B; Thomas S; Marks N; Yang AJ
Brain Res Bull; 2003 Feb; 59(6):523-31. PubMed ID: 12576150
[TBL] [Abstract][Full Text] [Related]
3. Endosomal-lysosomal dysfunctions in Alzheimer's disease: Pathogenesis and therapeutic interventions.
Lai SSM; Ng KY; Koh RY; Chok KC; Chye SM
Metab Brain Dis; 2021 Aug; 36(6):1087-1100. PubMed ID: 33881723
[TBL] [Abstract][Full Text] [Related]
4. Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer's disease and Down syndrome: differential effects of APOE genotype and presenilin mutations.
Cataldo AM; Peterhoff CM; Troncoso JC; Gomez-Isla T; Hyman BT; Nixon RA
Am J Pathol; 2000 Jul; 157(1):277-86. PubMed ID: 10880397
[TBL] [Abstract][Full Text] [Related]
5. Increased neuronal endocytosis and protease delivery to early endosomes in sporadic Alzheimer's disease: neuropathologic evidence for a mechanism of increased beta-amyloidogenesis.
Cataldo AM; Barnett JL; Pieroni C; Nixon RA
J Neurosci; 1997 Aug; 17(16):6142-51. PubMed ID: 9236226
[TBL] [Abstract][Full Text] [Related]
6. The autophagy-lysosomal degradation pathway: role in neurodegenerative disease and therapy.
Shacka JJ; Roth KA; Zhang J
Front Biosci; 2008 Jan; 13():718-36. PubMed ID: 17981582
[TBL] [Abstract][Full Text] [Related]
7. Methods to Characterize Synthesis and Degradation of Sphingomyelin at the Plasma Membrane and Its Impact on Lipid Raft Dynamics.
Nikolova-Karakashian M
Methods Mol Biol; 2021; 2187():113-129. PubMed ID: 32770504
[TBL] [Abstract][Full Text] [Related]
8. Impaired axonal retrograde trafficking of the retromer complex augments lysosomal deficits in Alzheimer's disease neurons.
Tammineni P; Jeong YY; Feng T; Aikal D; Cai Q
Hum Mol Genet; 2017 Nov; 26(22):4352-4366. PubMed ID: 28973312
[TBL] [Abstract][Full Text] [Related]
9. Acid Sphingomyelinase, a Lysosomal and Secretory Phospholipase C, Is Key for Cellular Phospholipid Catabolism.
Breiden B; Sandhoff K
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445706
[TBL] [Abstract][Full Text] [Related]
10. Amyloid precursor protein and endosomal-lysosomal dysfunction in Alzheimer's disease: inseparable partners in a multifactorial disease.
Nixon RA
FASEB J; 2017 Jul; 31(7):2729-2743. PubMed ID: 28663518
[TBL] [Abstract][Full Text] [Related]
11. Uncovering the role of Snapin in regulating autophagy-lysosomal function.
Cai Q; Sheng ZH
Autophagy; 2011 Apr; 7(4):445-7. PubMed ID: 21233602
[TBL] [Abstract][Full Text] [Related]
12. Lysosomal-associated transmembrane protein 4B regulates ceramide-induced exosome release.
Yuyama K; Sun H; Mikami D; Mioka T; Mukai K; Igarashi Y
FASEB J; 2020 Dec; 34(12):16022-16033. PubMed ID: 33090522
[TBL] [Abstract][Full Text] [Related]
13. Dysfunction of autophagy and endosomal-lysosomal pathways: Roles in pathogenesis of Down syndrome and Alzheimer's Disease.
Colacurcio DJ; Pensalfini A; Jiang Y; Nixon RA
Free Radic Biol Med; 2018 Jan; 114():40-51. PubMed ID: 28988799
[TBL] [Abstract][Full Text] [Related]
14. Tracking sphingosine metabolism and transport in sphingolipidoses: NPC1 deficiency as a test case.
Blom T; Li Z; Bittman R; Somerharju P; Ikonen E
Traffic; 2012 Sep; 13(9):1234-43. PubMed ID: 22607065
[TBL] [Abstract][Full Text] [Related]
15. Use of N-[5-(5,7-dimethyl boron dipyrromethene difluoride-sphingomyelin to study membrane traffic along the endocytic pathway.
Pagano RE; Watanabe R; Wheatley C; Chen CS
Chem Phys Lipids; 1999 Nov; 102(1-2):55-63. PubMed ID: 11001561
[TBL] [Abstract][Full Text] [Related]
16. Lysosomal involvement in cellular turnover of plasma membrane sphingomyelin.
Sutrina SL; Chen WW
Biochim Biophys Acta; 1984 Apr; 793(2):169-79. PubMed ID: 6424713
[TBL] [Abstract][Full Text] [Related]
17. Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease.
Cutler RG; Kelly J; Storie K; Pedersen WA; Tammara A; Hatanpaa K; Troncoso JC; Mattson MP
Proc Natl Acad Sci U S A; 2004 Feb; 101(7):2070-5. PubMed ID: 14970312
[TBL] [Abstract][Full Text] [Related]
18. Sulfatide and sphingomyelin loading of living cells as tools for the study of ceramide turnover by lysosomal ceramidase--implications for the diagnosis of Farber disease.
Levade T; Tempesta MC; Moser HW; Fensom AH; Harzer K; Moser AB; Salvayre R
Biochem Mol Med; 1995 Apr; 54(2):117-25. PubMed ID: 8581356
[TBL] [Abstract][Full Text] [Related]
19. The endosomal-lysosomal system of neurons in Alzheimer's disease pathogenesis: a review.
Nixon RA; Cataldo AM; Mathews PM
Neurochem Res; 2000 Oct; 25(9-10):1161-72. PubMed ID: 11059790
[TBL] [Abstract][Full Text] [Related]
20. TRPMLs and TPCs: Targets for lysosomal storage and neurodegenerative disease therapy?
Krogsaeter E; Rosato AS; Grimm C
Cell Calcium; 2022 May; 103():102553. PubMed ID: 35144097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
